Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.

No Thumbnail Available
Date
2009-05-23
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
Rishi P, Rishi E, Shroff D. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia. Indian Journal of Ophthalmology. 2009 May-Jun; 57(3): 241-2
URI
https://imsear.searo.who.int/handle/123456789/70491
Collections
Indian Journal of Ophthalmology